Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial

Chemotherapy. 1974;20(3):183-200. doi: 10.1159/000221808.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aminosalicylic Acids / administration & dosage
  • Aminosalicylic Acids / adverse effects
  • Aminosalicylic Acids / therapeutic use*
  • Blood Proteins / analysis
  • Blood Sedimentation
  • Body Weight
  • Clinical Trials as Topic
  • Drug Evaluation
  • Drug Therapy, Combination / adverse effects
  • Female
  • Humans
  • Isoniazid / administration & dosage
  • Isoniazid / adverse effects
  • Isoniazid / therapeutic use*
  • Male
  • Mycobacterium bovis
  • Radiography
  • Rifampin / administration & dosage
  • Rifampin / adverse effects
  • Rifampin / therapeutic use*
  • Sputum / microbiology
  • Tuberculosis, Pulmonary / blood
  • Tuberculosis, Pulmonary / diagnostic imaging
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Aminosalicylic Acids
  • Blood Proteins
  • Isoniazid
  • Rifampin